EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cognitive changes associated with chemotherapy in breast cancer. An assessment of social cognition and executive functions in Peruvian patients

Sandro Casavilca-Zambrano iD, Nilton Custodio iD, Ruddy Liendo-Picoaga iD, Juan José Contreras Mancilla iD, Jenny Katherine Bonifacio Mundaca iD, Rosa Montesinos iD, Laura Fejerman iD, Valentina Zavala iD, Stéphane Bertani iD, Jorge Honles iD, Tatiana Vidaurre iD

The Oncologist · 2026

DOI: 10.1093/oncolo/oyag058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2026. Verfasst von Sandro Casavilca-Zambrano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias de la Salud, Universidad de Huánuco, Huánuco, Peru. Hauptthemen laut MEDLINE: Breast Neoplasms, Social Cognition, Executive Function, Cognition. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tecnología e Innovación Tecnológica (CONCYTEC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cognitive impairment related to chemotherapy—commonly referred to as “chemo brain”—is a well-documented phenomenon among breast cancer patients. These impairments affect memory, attention, executive function, and social cognition, yet remain understudied in low- and middle-income countries. In Peru, where populations present a high proportion of Amerindian ancestry and distinct sociocultural factors, evidence is scarce.

Methods

We conducted a longitudinal study of 143 Peruvian women aged 28–64 years, newly diagnosed with early-stage breast cancer and naïve to chemotherapy, treated at the National Institute of Neoplastic Diseases (INEN) in Lima. Cognitive function was assessed using the Addenbrooke’s Cognitive Examination (ACE), the INECO Frontal Screening Test (IFS), and a Facial Emotion Recognition (FER) task to evaluate social cognition. Baseline tests were performed before the start of treatment for each patient, and post-treatment tests were performed every 3 months. Global genetic ancestry was estimated using the ADMIXTURE algorithm based on the Affymetrix Precision Medicine Research Array.

Results

Native American ancestry accounted for 77.8% of the study population. Post-chemotherapy assessments revealed cognitive impairment in 21% of patients based on FER, 15% on ACE, and 12% on IFS. Higher educational attainment was associated with better cognitive performance across all domains.

Conclusion

Chemotherapy was associated with measurable cognitive decline in a subset of Peruvian breast cancer patients. Brief and culturally adaptable tools such as the FER test offer a promising approach for routine cognitive screening in oncology settings, particularly in resource-limited contexts. Incorporating these assessments into standard care may facilitate early detection and more personalized supportive interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsSocial CognitionExecutive FunctionCognitionHumansFemalePeruMiddle AgedAdultLongitudinal Studies

Stichwörter der Autor:innen

ancestryantineoplastic drugsbreast cancerchemotherapy-related cognitive impairmentsocial cognition

Autor:innen und Institutionen

  • Facultad de Ciencias de la Salud, Universidad de Huánuco, Huánuco, Peru.
  • Unidad Funcional de Gestión del Banco Nacional de Tumores, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru.
  • Instituto Peruano de Neurociencias, Lima, Peru.
  • Laboratory of Cell Culture and Immunology Research, Universidad Científica del Sur, Lima, Peru.
  • International Joint Laboratory of Molecular Anthropological Oncology (LOAM), INEN-IRD, Lima, Peru.
  • UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, United States.

ORCID-Profile: Sandro Casavilca-Zambrano, Nilton Custodio, Ruddy Liendo-Picoaga, Juan José Contreras Mancilla, Jenny Katherine Bonifacio Mundaca, Rosa Montesinos, Laura Fejerman, Valentina Zavala, Stéphane Bertani, Jorge Honles, Tatiana Vidaurre

Förderung

  • Tecnología e Innovación Tecnológica (CONCYTEC)

Zitieren

APA

Casavilca-Zambrano, S., Custodio, N., Liendo-Picoaga, R., Contreras Mancilla, J. J., Bonifacio Mundaca, J. K., Montesinos, R., Fejerman, L., Zavala, V., Bertani, S., Honles, J., & Vidaurre, T. (2026). Cognitive changes associated with chemotherapy in breast cancer. An assessment of social cognition and executive functions in Peruvian patients. The Oncologist. https://doi.org/10.1093/oncolo/oyag058

Vancouver

Casavilca-Zambrano S, Custodio N, Liendo-Picoaga R, Contreras Mancilla JJ, Bonifacio Mundaca JK, Montesinos R, et al. Cognitive changes associated with chemotherapy in breast cancer. An assessment of social cognition and executive functions in Peruvian patients. The Oncologist. 2026. doi:10.1093/oncolo/oyag058

BibTeX
@article{CasavilcaZambrano2026,
  author = {Casavilca-Zambrano, Sandro and Custodio, Nilton and Liendo-Picoaga, Ruddy and Contreras Mancilla, Juan José and Bonifacio Mundaca, Jenny Katherine and Montesinos, Rosa and Fejerman, Laura and Zavala, Valentina and Bertani, Stéphane and Honles, Jorge and Vidaurre, Tatiana},
  title = {Cognitive changes associated with chemotherapy in breast cancer. An assessment of social cognition and executive functions in Peruvian patients},
  journal = {The Oncologist},
  year = {2026},
  doi = {10.1093/oncolo/oyag058}
}
Kostenlos starten →